BindingDB logo
myBDB logout
Compile Data Set for Download or QSAR

Marvin 2D Structure

The following exact ligands are found in BindingDB

Wt: 568.6
BDBM445229

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB (change energy unit to kcal/mol)

Found 12 hits in this display   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kJ/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Platelet-derived growth factor receptor beta


(Homo sapiens (Human))
BDBM445229
PNG
(US10669235, Example 20 | US11208381, Example 20)
Show SMILES COCCN1CCC(CC1)NC(=O)c1ccc(N\C(=C2/C(=O)Nc3cc(C(=O)OC)c(C)cc23)c2ccccc2)cc1
Show InChI InChI=1S/C33H36N4O5/c1-21-19-27-28(20-26(21)33(40)42-3)36-32(39)29(27)30(22-7-5-4-6-8-22)34-24-11-9-23(10-12-24)31(38)35-25-13-15-37(16-14-25)17-18-41-2/h4-12,19-20,25,34H,13-18H2,1-3H3,(H,35,38)(H,36,39)/b30-29-
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
19.1n/an/an/an/an/an/an/an/a



RESPIVERT LIMITED

US Patent


Assay Description
The inhibitory activities of compounds of the invention against PDGFRβ (PDGFRβ Kinase Enzyme System: Promega), were evaluated by mixing the...


US Patent US10669235 (2020)


BindingDB Entry DOI: 10.7270/Q2XW4NVJ
More data for this
Ligand-Target Pair
Platelet-derived growth factor receptor beta


(Homo sapiens (Human))
BDBM445229
PNG
(US10669235, Example 20 | US11208381, Example 20)
Show SMILES COCCN1CCC(CC1)NC(=O)c1ccc(N\C(=C2/C(=O)Nc3cc(C(=O)OC)c(C)cc23)c2ccccc2)cc1
Show InChI InChI=1S/C33H36N4O5/c1-21-19-27-28(20-26(21)33(40)42-3)36-32(39)29(27)30(22-7-5-4-6-8-22)34-24-11-9-23(10-12-24)31(38)35-25-13-15-37(16-14-25)17-18-41-2/h4-12,19-20,25,34H,13-18H2,1-3H3,(H,35,38)(H,36,39)/b30-29-
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
19.1n/an/an/an/an/an/an/an/a


TBA

Assay Description
Assay was performed in buffer containing 40 mM Tris pH 7.5, 20 mM MgCl2, 0.1 mg/mL BSA and 1 mM DTT. The inhibitory activities of compounds of the in...


Citation and Details

BindingDB Entry DOI: 10.7270/Q2XP784N
More data for this
Ligand-Target Pair
Platelet-derived growth factor receptor alpha


(Homo sapiens (Human))
BDBM445229
PNG
(US10669235, Example 20 | US11208381, Example 20)
Show SMILES COCCN1CCC(CC1)NC(=O)c1ccc(N\C(=C2/C(=O)Nc3cc(C(=O)OC)c(C)cc23)c2ccccc2)cc1
Show InChI InChI=1S/C33H36N4O5/c1-21-19-27-28(20-26(21)33(40)42-3)36-32(39)29(27)30(22-7-5-4-6-8-22)34-24-11-9-23(10-12-24)31(38)35-25-13-15-37(16-14-25)17-18-41-2/h4-12,19-20,25,34H,13-18H2,1-3H3,(H,35,38)(H,36,39)/b30-29-
PDB

KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
24.2n/an/an/an/an/an/an/an/a


TBA

Assay Description
Assay was performed in buffer containing 40 mM Tris pH 7.5, 20 mM MgCl2, 0.1 mg/mL BSA and 1 mM DTT. The inhibitory activities of compounds of the in...


Citation and Details

BindingDB Entry DOI: 10.7270/Q2XP784N
More data for this
Ligand-Target Pair
Platelet-derived growth factor receptor alpha


(Homo sapiens (Human))
BDBM445229
PNG
(US10669235, Example 20 | US11208381, Example 20)
Show SMILES COCCN1CCC(CC1)NC(=O)c1ccc(N\C(=C2/C(=O)Nc3cc(C(=O)OC)c(C)cc23)c2ccccc2)cc1
Show InChI InChI=1S/C33H36N4O5/c1-21-19-27-28(20-26(21)33(40)42-3)36-32(39)29(27)30(22-7-5-4-6-8-22)34-24-11-9-23(10-12-24)31(38)35-25-13-15-37(16-14-25)17-18-41-2/h4-12,19-20,25,34H,13-18H2,1-3H3,(H,35,38)(H,36,39)/b30-29-
PDB

KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
24.2n/an/an/an/an/an/an/an/a



RESPIVERT LIMITED

US Patent


Assay Description
The inhibitory activities of compounds of the invention against PDGFRα (PDGFRα Kinase Enzyme System: Promega), were evaluated by mixing the...


US Patent US10669235 (2020)


BindingDB Entry DOI: 10.7270/Q2XW4NVJ
More data for this
Ligand-Target Pair
Fibroblast growth factor receptor 3


(Homo sapiens (Human))
BDBM445229
PNG
(US10669235, Example 20 | US11208381, Example 20)
Show SMILES COCCN1CCC(CC1)NC(=O)c1ccc(N\C(=C2/C(=O)Nc3cc(C(=O)OC)c(C)cc23)c2ccccc2)cc1
Show InChI InChI=1S/C33H36N4O5/c1-21-19-27-28(20-26(21)33(40)42-3)36-32(39)29(27)30(22-7-5-4-6-8-22)34-24-11-9-23(10-12-24)31(38)35-25-13-15-37(16-14-25)17-18-41-2/h4-12,19-20,25,34H,13-18H2,1-3H3,(H,35,38)(H,36,39)/b30-29-
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
30n/an/an/an/an/an/an/an/a



RESPIVERT LIMITED

US Patent


Assay Description
The inhibitory activities of compounds of the invention against FGFR3 (FGFR3 Kinase Enzyme System: Promega), were evaluated by mixing the FGFR3 prote...


US Patent US10669235 (2020)


BindingDB Entry DOI: 10.7270/Q2XW4NVJ
More data for this
Ligand-Target Pair
Fibroblast growth factor receptor 3


(Homo sapiens (Human))
BDBM445229
PNG
(US10669235, Example 20 | US11208381, Example 20)
Show SMILES COCCN1CCC(CC1)NC(=O)c1ccc(N\C(=C2/C(=O)Nc3cc(C(=O)OC)c(C)cc23)c2ccccc2)cc1
Show InChI InChI=1S/C33H36N4O5/c1-21-19-27-28(20-26(21)33(40)42-3)36-32(39)29(27)30(22-7-5-4-6-8-22)34-24-11-9-23(10-12-24)31(38)35-25-13-15-37(16-14-25)17-18-41-2/h4-12,19-20,25,34H,13-18H2,1-3H3,(H,35,38)(H,36,39)/b30-29-
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
30n/an/an/an/an/an/an/an/a


TBA

Assay Description
Assay was performed in buffer containing 40 mM Tris pH 7.5, 20 mM MgCl2, 0.1 mg/mL BSA, 1 mM DTT and 2 mM MnCl2. The inhibitory activities of compoun...


Citation and Details

BindingDB Entry DOI: 10.7270/Q2XP784N
More data for this
Ligand-Target Pair
Fibroblast growth factor receptor 1


(Homo sapiens (Human))
BDBM445229
PNG
(US10669235, Example 20 | US11208381, Example 20)
Show SMILES COCCN1CCC(CC1)NC(=O)c1ccc(N\C(=C2/C(=O)Nc3cc(C(=O)OC)c(C)cc23)c2ccccc2)cc1
Show InChI InChI=1S/C33H36N4O5/c1-21-19-27-28(20-26(21)33(40)42-3)36-32(39)29(27)30(22-7-5-4-6-8-22)34-24-11-9-23(10-12-24)31(38)35-25-13-15-37(16-14-25)17-18-41-2/h4-12,19-20,25,34H,13-18H2,1-3H3,(H,35,38)(H,36,39)/b30-29-
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
48.5n/an/an/an/an/an/an/an/a



RESPIVERT LIMITED

US Patent


Assay Description
The inhibitory activities of compounds of the invention against FGFR1 (FGFR1 Kinase Enzyme System: Promega), were evaluated by mixing the FGFR1 prote...


US Patent US10669235 (2020)


BindingDB Entry DOI: 10.7270/Q2XW4NVJ
More data for this
Ligand-Target Pair
Fibroblast growth factor receptor 1


(Homo sapiens (Human))
BDBM445229
PNG
(US10669235, Example 20 | US11208381, Example 20)
Show SMILES COCCN1CCC(CC1)NC(=O)c1ccc(N\C(=C2/C(=O)Nc3cc(C(=O)OC)c(C)cc23)c2ccccc2)cc1
Show InChI InChI=1S/C33H36N4O5/c1-21-19-27-28(20-26(21)33(40)42-3)36-32(39)29(27)30(22-7-5-4-6-8-22)34-24-11-9-23(10-12-24)31(38)35-25-13-15-37(16-14-25)17-18-41-2/h4-12,19-20,25,34H,13-18H2,1-3H3,(H,35,38)(H,36,39)/b30-29-
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
48.5n/an/an/an/an/an/an/an/a


TBA

Assay Description
Assay was performed in buffer containing 40 mM Tris pH 7.5, 20 mM MgCl2, 0.1 mg/mL BSA and 1 mM DTT. The inhibitory activities of compounds of the in...


Citation and Details

BindingDB Entry DOI: 10.7270/Q2XP784N
More data for this
Ligand-Target Pair
Vascular endothelial growth factor receptor 2


(Homo sapiens (Human))
BDBM445229
PNG
(US10669235, Example 20 | US11208381, Example 20)
Show SMILES COCCN1CCC(CC1)NC(=O)c1ccc(N\C(=C2/C(=O)Nc3cc(C(=O)OC)c(C)cc23)c2ccccc2)cc1
Show InChI InChI=1S/C33H36N4O5/c1-21-19-27-28(20-26(21)33(40)42-3)36-32(39)29(27)30(22-7-5-4-6-8-22)34-24-11-9-23(10-12-24)31(38)35-25-13-15-37(16-14-25)17-18-41-2/h4-12,19-20,25,34H,13-18H2,1-3H3,(H,35,38)(H,36,39)/b30-29-
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
83.7n/an/an/an/an/an/an/an/a


TBA

Assay Description
Assay was performed in buffer containing 40 mM Tris pH 7.5, 20 mM MgCl2, 0.1 mg/mL BSA and 1 mM DTT. The inhibitory activities of compounds of the in...


Citation and Details

BindingDB Entry DOI: 10.7270/Q2XP784N
More data for this
Ligand-Target Pair
Vascular endothelial growth factor receptor 2


(Homo sapiens (Human))
BDBM445229
PNG
(US10669235, Example 20 | US11208381, Example 20)
Show SMILES COCCN1CCC(CC1)NC(=O)c1ccc(N\C(=C2/C(=O)Nc3cc(C(=O)OC)c(C)cc23)c2ccccc2)cc1
Show InChI InChI=1S/C33H36N4O5/c1-21-19-27-28(20-26(21)33(40)42-3)36-32(39)29(27)30(22-7-5-4-6-8-22)34-24-11-9-23(10-12-24)31(38)35-25-13-15-37(16-14-25)17-18-41-2/h4-12,19-20,25,34H,13-18H2,1-3H3,(H,35,38)(H,36,39)/b30-29-
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
83.7n/an/an/an/an/an/an/an/a



RESPIVERT LIMITED

US Patent


Assay Description
The inhibitory activities of compounds of the invention against VEGFR2 (VEGFR2 Kinase Enzyme System: Promega), were evaluated by mixing the VEGFR2 pr...


US Patent US10669235 (2020)


BindingDB Entry DOI: 10.7270/Q2XW4NVJ
More data for this
Ligand-Target Pair
Vascular endothelial growth factor receptor 1


(Homo sapiens (Human))
BDBM445229
PNG
(US10669235, Example 20 | US11208381, Example 20)
Show SMILES COCCN1CCC(CC1)NC(=O)c1ccc(N\C(=C2/C(=O)Nc3cc(C(=O)OC)c(C)cc23)c2ccccc2)cc1
Show InChI InChI=1S/C33H36N4O5/c1-21-19-27-28(20-26(21)33(40)42-3)36-32(39)29(27)30(22-7-5-4-6-8-22)34-24-11-9-23(10-12-24)31(38)35-25-13-15-37(16-14-25)17-18-41-2/h4-12,19-20,25,34H,13-18H2,1-3H3,(H,35,38)(H,36,39)/b30-29-
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
178n/an/an/an/an/an/an/an/a


TBA

Assay Description
Assay was performed in buffer containing 40 mM Tris pH 7.5, 20 mM MgCl2, 0.1 mg/mL BSA, 1 mM DTT and 2 mM MnCl2. The inhibitory activities of compoun...


Citation and Details

BindingDB Entry DOI: 10.7270/Q2XP784N
More data for this
Ligand-Target Pair
Vascular endothelial growth factor receptor 1


(Homo sapiens (Human))
BDBM445229
PNG
(US10669235, Example 20 | US11208381, Example 20)
Show SMILES COCCN1CCC(CC1)NC(=O)c1ccc(N\C(=C2/C(=O)Nc3cc(C(=O)OC)c(C)cc23)c2ccccc2)cc1
Show InChI InChI=1S/C33H36N4O5/c1-21-19-27-28(20-26(21)33(40)42-3)36-32(39)29(27)30(22-7-5-4-6-8-22)34-24-11-9-23(10-12-24)31(38)35-25-13-15-37(16-14-25)17-18-41-2/h4-12,19-20,25,34H,13-18H2,1-3H3,(H,35,38)(H,36,39)/b30-29-
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
178n/an/an/an/an/an/an/an/a



RESPIVERT LIMITED

US Patent


Assay Description
The inhibitory activities of compounds of the invention against VEGFR1 (VEGFR1 Kinase Enzyme System: Promega), were evaluated by mixing the VEGFR1 pr...


US Patent US10669235 (2020)


BindingDB Entry DOI: 10.7270/Q2XW4NVJ
More data for this
Ligand-Target Pair